Kumiko Yoshimatsu Selected Research

Hantavirus Infections

7/2014	Serological diagnosis with recombinant N antigen for hantavirus infection.
5/2014	Development of an immunochromatography strip test based on truncated nucleocapsid antigens of three representative hantaviruses.
10/2012	Development of a serotyping enzyme-linked immunosorbent assay system based on recombinant truncated hantavirus nucleocapsid proteins for New World hantavirus infection.
9/2012	Development of a diagnostic method applicable to various serotypes of hantavirus infection in rodents.
2/2012	Application of truncated nucleocapsid protein (N) for serotyping ELISA of murinae-associated hantavirus infection in rats.
1/2011	Serological evidence of Thailand virus-related hantavirus infection among suspected leptospirosis patients in Kandy, Sri Lanka.
4/2009	Acute febrile illness caused by hantavirus: serological and molecular evidence from India.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kumiko Yoshimatsu Research Topics

Disease

15	Infections 01/2022 - 08/2003
7	Hantavirus Infections 07/2014 - 04/2009
7	Hemorrhagic Fever with Renal Syndrome (HFRS) 05/2014 - 01/2003
3	Severe Fever with Thrombocytopenia Syndrome 12/2020 - 07/2017
3	Fever (Fevers) 01/2017 - 02/2007
2	Communicable Diseases (Infectious Diseases) 05/2021 - 11/2019
2	Leptospirosis 12/2018 - 01/2011
2	Vesicular Stomatitis 04/2006 - 01/2003
1	Epidemic Louse-Borne Typhus (Typhus) 07/2017
1	Scrub Typhus (Typhus, Scrub) 07/2017
1	Spotted Fever Group Rickettsiosis (Rickettsialpox) 07/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Hepatomegaly 12/2016
1	Cutaneous Leishmaniasis 06/2016
1	Fever of Unknown Origin 01/2013
1	Jaundice (Icterus) 01/2012
1	Hemoptysis 01/2012
1	Anuria 01/2012
1	Thrombosis (Thrombus) 09/2011
1	Breast Neoplasms (Breast Cancer) 06/2011
1	Persistent Infection 01/2007
1	Japanese Encephalitis 03/2003
1	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 03/2003

Drug/Important Bio-Agent (IBA)

11	AntibodiesIBA 05/2021 - 11/2003
9	AntigensIBA 12/2018 - 03/2003
8	EnzymesIBA 12/2018 - 03/2003
7	ImmunosorbentsIBA 12/2018 - 03/2003
6	Nucleocapsid ProteinsIBA 10/2012 - 01/2008
4	Amino Acids FDA Link 12/2020 - 01/2008
4	Proteins (Proteins, Gene)FDA Link 12/2020 - 01/2003
4	Immunoglobulin G (IgG)IBA 07/2017 - 04/2009
3	Monoclonal AntibodiesIBA 12/2018 - 01/2003
3	Glycoproteins (Glycoprotein)IBA 01/2017 - 01/2003
2	Immunoglobulin M (IgM)IBA 12/2021 - 04/2009
2	Neutralizing AntibodiesIBA 01/2017 - 05/2004
2	Viral RNAIBA 09/2011 - 01/2007
2	VaccinesIBA 11/2008 - 04/2006
2	EpitopesIBA 09/2007 - 02/2007
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2022
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2022
1	Viral Structural Proteins (VP(1))IBA 01/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2016
1	Alanine Transaminase (SGPT)IBA 12/2016
1	DNA (Deoxyribonucleic Acid)IBA 06/2016
1	Indicators and Reagents (Reagents)IBA 09/2012
1	NucleotidesIBA 04/2011
1	Heterophile AntigensIBA 12/2010
1	4-hexyloxyaniline (HOA)IBA 10/2009
1	RNA (Ribonucleic Acid)IBA 01/2007
1	Interferon-gamma (Interferon, gamma)IBA 08/2003

Therapy/Procedure

1	Intravenous Injections 04/2013
1	Treatment Delay 01/2012